Mark T Bertolini bought $11.9M of Oscar Health (OSCR)
Executed Apr 6, disclosed Apr 7, 1 day later.
Over the 21 trading sessions from the disclosed entry session (Apr 7), the stock returned +38.4% (delay-adjusted); from the execution session (Apr 6), +54.7%. Derived: entry at the session's open, exit at the close 20 sessions later.
Mark T Bertolini (Chief Executive Officer) filed 3 Form 4 reports in the trailing twelve months (1 purchase, 2 sales), most often in Oscar Health, Inc. (OSCR). Across 1 priced purchase filing, the average 21-session return was +54.7% from execution and +38.4% from disclosure (delay-adjusted; derived). The largest single filing was $35.8M of OSCR (1,238,996 sh across 4 lots, as filed), executed Jun 29.
Healthcare · Oscar Health, Inc. operates as a healthcare technology company in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→1,238,996 sh across 4 lots
Exec Jun 29
Filed Jul 1 · 4:16 PM ET OSCRSALE Oscar Health, Inc. $34.9M
1,206,310 sh across 4 lots
Exec Jun 25
Filed Jun 29 · 5:30 PM ET